ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.
about
Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway AnalysisActivation status of the pregnane X receptor influences vemurafenib availability in humanized mouse models.A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.A phosphotyrosine switch regulates organic cation transporters.Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.Modulation of Multidrug Resistance Protein 2 Efflux in the Cisplatin Resistance Human Ovarian Carcinoma Cells A2780/RCIS by Sesquiterpene Coumarins.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1.Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated efflux.
P2860
Q28545978-87DD087B-F1E8-4C77-9381-99AEA593F49EQ36251418-81072D3E-B70E-4136-9E33-6DEF924F617AQ36544506-8F0CB154-C2DF-4B5A-A561-A287B613D387Q36604036-61E8017B-88D5-4914-A9A7-1020C88476FBQ36704820-28D55F58-1073-45A3-956D-F4679C6C93A5Q38818023-C9AAA4D3-EAAE-40FA-9C56-BA26F367391DQ38824820-9FFCE9CD-F877-49D1-8B4E-0F35A48B87F0Q39031326-B93021D3-A20A-4352-B941-AE159D68F22DQ42654010-E0D412A5-ACB6-4242-A6E0-D8DD1C9FD3C6Q46028686-8E14737F-0DF9-4B82-A060-22102428E77CQ47895186-1D79215E-CCE7-4D75-BEF8-251B10858B01Q49888021-B2E68F2F-2520-4127-807D-6FF3EDCE4052Q50784573-D1DD4E6D-80C2-41B5-A01A-9C7C7BBC95C6
P2860
ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
ABC transporters in multi-drug ...... le tyrosine kinase inhibitors.
@ast
ABC transporters in multi-drug ...... le tyrosine kinase inhibitors.
@en
type
label
ABC transporters in multi-drug ...... le tyrosine kinase inhibitors.
@ast
ABC transporters in multi-drug ...... le tyrosine kinase inhibitors.
@en
prefLabel
ABC transporters in multi-drug ...... le tyrosine kinase inhibitors.
@ast
ABC transporters in multi-drug ...... le tyrosine kinase inhibitors.
@en
P2093
P2860
P1476
ABC transporters in multi-drug ...... le tyrosine kinase inhibitors.
@en
P2093
Jiexin Deng
John S Markowitz
P2860
P304
P356
10.1007/S11095-014-1389-0
P577
2014-05-20T00:00:00Z